Clinical Study of Single Incision Laparoscopic Cholecystectomy in the Treatment of Patients With Acute Cholecystitis
NCT ID: NCT06074679
Last Updated: 2024-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
600 participants
INTERVENTIONAL
2023-10-01
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single Incision Laparoscopic Cholecystectomy Compared with Conventional Laparoscopic Cholecystectomy, a Randomized Controlled Clinical Study
NCT05728463
Study of the Inflammatory Reaction in Standard vs Single Port Cholecystectomy for Uncomplicated Cholelithiasis
NCT01116492
Intraoperative Spillage of Bile and Gallstones During Laparoscopic Cholecysetectomy
NCT04041726
Role of Routine on-Table Cholangiography in Laparoscopic Cholecystectomy
NCT00806780
Single Setting ERCP and Laparoscopic Cholecystectomy is a Safe Procedure in Patients With Cholecysto-Choledocholithiasis
NCT04213092
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single-incision laparoscopic cholecystectomy
SILC was defined as laparoscopic surgery done through a single trans-umbilical incision
Open cholecystectomy
The experimental group and the control group were changed to open cholecystectomy when the operation was difficult to complete.
Conventional laparoscopic cholecystectomy
CLC was defined as three or four port surgery carried out with either French or American position.
Open cholecystectomy
The experimental group and the control group were changed to open cholecystectomy when the operation was difficult to complete.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Open cholecystectomy
The experimental group and the control group were changed to open cholecystectomy when the operation was difficult to complete.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Upper abdominal surgical history;
* Changes in surgical plan (conversion to laparotomy,cholangiography, bile duct exploration, bile duct injury repair, abscess clearance, multivisceral resection.)
* Patients and their families do not agree with the treatment lost follow-up
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Changxing Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
UNKNOWN
Suichang Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
UNKNOWN
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
UNKNOWN
Shexian Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
UNKNOWN
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liu Daren, MD, PhD
Role: STUDY_DIRECTOR
Chief Physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shexian Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Huangshan City, Anhui, China
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, China
Changxing Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Huzhou, Zhejiang, China
Suichang Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Lishui, Zhejiang, China
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Meicheng, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Liu Xiaojun
Role: primary
Hu Yongfeng
Role: primary
Lan Weifeng
Role: primary
Peng Junwen
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-0690
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.